title: Deal watch: AstraZeneca bets on FibroGen's anaemia drug.
authors.forename: Monica Hoyos
authors.initials: MH
authors.lastname: Flight
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D017326:Clinical Trials, Phase III as Topic; D003299:Cooperative Behavior; D015195:Drug Design; D004345:Drug Industry / Q000191:economics*; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D005998:Glycine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology / Q000627:therapeutic use*; D011393:Procollagen-Proline Dioxygenase / Q000037:antagonists & inhibitors; D051436:Renal Insufficiency, Chronic / Q000150:complications
chemical_list: D004791:Enzyme Inhibitors; D007546:Isoquinolines; D011393:Procollagen-Proline Dioxygenase; D005998:Glycine; C584543:roxadustat